{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:43:37Z","timestamp":1784641417755,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"a Health and Labour Sciences Research Grant on Rare and Intractable Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10067-020-04971-2","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T16:02:36Z","timestamp":1581177756000},"page":"1803-1811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis"],"prefix":"10.1007","volume":"39","author":[{"given":"Junji","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7100-1121","authenticated-orcid":false,"given":"Yasuhiro","family":"Shimojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Usami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,8]]},"reference":[{"key":"4971_CR1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/jnnp-2013-306410","volume":"85","author":"T Yonekawa","year":"2014","unstructured":"Yonekawa T, Murai H, Utsuki S, Matsushita T, Masaki K, Isobe N, Yamasaki R, Yoshida M, Kusunoki S, Sakata K, Fujii K, Kira J (2014) A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry 85:732\u2013739","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4971_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cyto.2017.08.013","volume":"99","author":"Y Shimojima","year":"2017","unstructured":"Shimojima Y, Kishida D, Sekijima Y (2017) Increased BAFF and APRIL levels in the cerebrospinal fluid of patients with anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis. Cytokine 99:305\u2013309","journal-title":"Cytokine"},{"key":"4971_CR3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/brain\/awt314","volume":"137","author":"A Yokoseki","year":"2014","unstructured":"Yokoseki A, Saji E, Arakawa M, Kosaka T, Hokari M, Toyoshima Y, Okamoto K, Takeda S, Sanpei K, Kikuchi H, Hirohata S, Akazawa K, Kakita A, Takahashi H, Nishizawa M, Kawachi I (2014) Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain 137:520\u2013536","journal-title":"Brain"},{"key":"4971_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/1756-185X.13046","volume":"20","author":"Y Shimojima","year":"2017","unstructured":"Shimojima Y, Kishida D, Hineno A, Yazaki M, Sekijima Y, Ikeda SI (2017) Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: a retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis. Int J Rheum Dis 20:489\u2013496","journal-title":"Int J Rheum Dis"},{"key":"4971_CR5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1440-1789.2003.00520.x","volume":"23","author":"S Riku","year":"2003","unstructured":"Riku S, Kato S (2003) Idiopathic hypertrophic pachymeningitis. Neuropathology 23:335\u2013344","journal-title":"Neuropathology"},{"key":"4971_CR6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","volume":"92","author":"ZS Wallace","year":"2013","unstructured":"Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, Deshpande V, Stone JH (2013) IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 92:206\u2013216","journal-title":"Medicine (Baltimore)"},{"key":"4971_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2019.01.010","volume":"330","author":"X Zhang","year":"2019","unstructured":"Zhang X, Fujii T, Ogata H, Yamasaki R, Masaki K, Cui Y, Matsushita T, Isobe N, Kira JI (2019) Cerebrospinal fluid cytokine\/chemokine\/growth factor profiles in idiopathic hypertrophic pachymeningitis. J Neuroimmunol 330:38\u201343","journal-title":"J Neuroimmunol"},{"key":"4971_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.06.006","volume":"200","author":"K Hamzaoui","year":"2008","unstructured":"Hamzaoui K, Houman H, Hentati F, Hamzaoui A (2008) BAFF is up-regulated in central nervous system of neuro-Behcet\u2019s disease. J Neuroimmunol 200:111\u2013114","journal-title":"J Neuroimmunol"},{"key":"4971_CR9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-3083.2012.02694.x","volume":"75","author":"Y Sumita","year":"2012","unstructured":"Sumita Y, Murakawa Y, Sugiura T, Wada Y, Nagai A, Yamaguchi S (2012) Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behcet\u2019s disease: BAFF is correlated with progressive dementia and psychosis. Scand J Immunol 75:633\u2013640","journal-title":"Scand J Immunol"},{"key":"4971_CR10","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2484","volume":"10","author":"A George-Chandy","year":"2008","unstructured":"George-Chandy A, Trysberg E, Eriksson K (2008) Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res Ther 10:R97","journal-title":"Arthritis Res Ther"},{"key":"4971_CR11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10875-012-9709-9","volume":"32","author":"H Wang","year":"2012","unstructured":"Wang H, Wang K, Zhong X, Qiu W, Dai Y, Wu A, Hu X (2012) Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse. J Clin Immunol 32:1007\u20131011","journal-title":"J Clin Immunol"},{"key":"4971_CR12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12026-016-8863-1","volume":"65","author":"A De Virgilio","year":"2017","unstructured":"De Virgilio A, de Vincentiis M, Inghilleri M, Fabrini G, Conte M, Gallo A, Rizzo MI, Greco A (2017) Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease. Immunol Res 65:386\u2013394","journal-title":"Immunol Res"},{"key":"4971_CR13","first-page":"352","volume":"91","author":"Y Shimojima","year":"2019","unstructured":"Shimojima Y (2019) Hypertrophic pachymeningitis related to ANCA associated vasculitis. Neurology (in Japanese) 91:352\u2013360","journal-title":"Neurology (in Japanese)"},{"key":"4971_CR14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000450850","volume":"8","author":"S Ushiyama","year":"2016","unstructured":"Ushiyama S, Kinoshita T, Shimojima Y, Ohashi N, Kishida D, Miyazaki D, Nakamura K, Sekijima Y, Ikeda SI (2016) Hypertrophic pachymeningitis as an early manifestation of relapsing polychondritis: case report and review of the literature. Case Rep Neurol 8:211\u2013217","journal-title":"Case Rep Neurol"},{"key":"4971_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"4971_CR16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222\u2013227","journal-title":"Ann Rheum Dis"},{"key":"4971_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","volume":"27","author":"H Umehara","year":"2017","unstructured":"Umehara H, Okazaki K, Nakamura T, Satoh-Nakamura T, Nakajima A, Kawano M, Mimori T, Chiba T (2017) Current approach to the diagnosis of IgG4-related disease\u2014combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol 27:381\u2013391","journal-title":"Mod Rheumatol"},{"key":"4971_CR18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","volume":"361","author":"RP Baughman","year":"2003","unstructured":"Baughman RP, Lower EE, du Bois RM (2003) Sarcoidosis. Lancet 361:1111\u20131118","journal-title":"Lancet"},{"key":"4971_CR19","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68:1827\u20131832","journal-title":"Ann Rheum Dis"},{"key":"4971_CR20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"HH Hu","year":"2018","unstructured":"Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND, Zhao YY (2018) New insights into TGF-beta\/Smad signaling in tissue fibrosis. Chem Biol Interact 292:76\u201383","journal-title":"Chem Biol Interact"},{"key":"4971_CR21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jns.2016.06.024","volume":"367","author":"LD Hahn","year":"2016","unstructured":"Hahn LD, Fulbright R, Baehring JM (2016) Hypertrophic pachymeningitis. J Neurol Sci 367:278\u2013283","journal-title":"J Neurol Sci"},{"key":"4971_CR22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","volume":"12","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Engelhardt B (2012) The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12:623\u2013635","journal-title":"Nat Rev Immunol"},{"key":"4971_CR23","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1172\/JCI58648","volume":"122","author":"DC Wraith","year":"2012","unstructured":"Wraith DC, Nicholson LB (2012) The adaptive immune system in diseases of the central nervous system. J Clin Invest 122:1172\u20131179","journal-title":"J Clin Invest"},{"key":"4971_CR24","doi-asserted-by":"crossref","unstructured":"Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Ten Dijke P (2017) TGF-beta-induced endothelial-mesenchymal transition in fibrotic diseases. Int J Mol Sci 18:2157","DOI":"10.3390\/ijms18102157"},{"key":"4971_CR25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","volume":"29","author":"A Biernacka","year":"2011","unstructured":"Biernacka A, Dobaczewski M, Frangogiannis NG (2011) TGF-beta signaling in fibrosis. Growth Factors 29:196\u2013202","journal-title":"Growth Factors"},{"key":"4971_CR26","unstructured":"Miyazawa K, Miyazono K (2017) Regulation of TGF-beta family signaling by inhibitory Smads. Cold Spring Harb Perspect Biol 9:a022095"},{"key":"4971_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2008.302","volume":"19","author":"X Guo","year":"2009","unstructured":"Guo X, Wang XF (2009) Signaling cross-talk between TGF-beta\/BMP and other pathways. Cell Res 19:71\u201388","journal-title":"Cell Res"},{"key":"4971_CR28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1189\/jlb.1007676","volume":"83","author":"HA Kim","year":"2008","unstructured":"Kim HA, Jeon SH, Seo GY, Park JB, Kim PH (2008) TGF-beta1 and IFN-gamma stimulate mouse macrophages to express BAFF via different signaling pathways. J Leukoc Biol 83:1431\u20131439","journal-title":"J Leukoc Biol"},{"key":"4971_CR29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10059-011-1040-4","volume":"32","author":"YS Jang","year":"2011","unstructured":"Jang YS, Kim JH, Seo GY, Kim PH (2011) TGF-beta1 stimulates mouse macrophages to express APRIL through Smad and p38MAPK\/CREB pathways. Mol Cell 32:251\u2013255","journal-title":"Mol Cell"},{"key":"4971_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","volume":"184","author":"H Reiber","year":"2001","unstructured":"Reiber H, Peter JB (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184:101\u2013122","journal-title":"J Neurol Sci"},{"key":"4971_CR31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.autrev.2015.06.001","volume":"14","author":"B Fitzner","year":"2015","unstructured":"Fitzner B, Hecker M, Zettl UK (2015) Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients. Autoimmun Rev 14:903\u2013913","journal-title":"Autoimmun Rev"},{"key":"4971_CR32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2006.04.004","volume":"18","author":"SG Tangye","year":"2006","unstructured":"Tangye SG, Bryant VL, Cuss AK, Good KL (2006) BAFF, APRIL and human B cell disorders. Semin Immunol 18:305\u2013317","journal-title":"Semin Immunol"},{"key":"4971_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1359-6101(03)00023-6","volume":"14","author":"F Mackay","year":"2003","unstructured":"Mackay F, Ambrose C (2003) The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev 14:311\u2013324","journal-title":"Cytokine Growth Factor Rev"},{"key":"4971_CR34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-065X.2011.01067.x","volume":"244","author":"RC Rickert","year":"2011","unstructured":"Rickert RC, Jellusova J, Miletic AV (2011) Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 244:115\u2013133","journal-title":"Immunol Rev"},{"key":"4971_CR35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10:463\u2013473","journal-title":"Nat Rev Rheumatol"},{"key":"4971_CR36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","volume":"25","author":"M Krumbholz","year":"2005","unstructured":"Krumbholz M, Specks U, Wick M, Kalled SL, Jenne D, Meinl E (2005) BAFF is elevated in serum of patients with Wegener\u2019s granulomatosis. J Autoimmun 25:298\u2013302","journal-title":"J Autoimmun"},{"key":"4971_CR37","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10067-010-1526-z","volume":"29","author":"L Bader","year":"2010","unstructured":"Bader L, Koldingsnes W, Nossent J (2010) B-lymphocyte activating factor levels are increased in patients with Wegener\u2019s granulomatosis and inversely correlated with ANCA titer. Clin Rheumatol 29:1031\u20131035","journal-title":"Clin Rheumatol"},{"key":"4971_CR38","doi-asserted-by":"crossref","first-page":"c339","DOI":"10.1159\/000323393","volume":"118","author":"M Nagai","year":"2011","unstructured":"Nagai M, Hirayama K, Ebihara I, Shimohata H, Kobayashi M, Koyama A (2011) Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity. Nephron Clin Pract 118:c339\u2013c345","journal-title":"Nephron Clin Pract"},{"key":"4971_CR39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/DDDT.S67264","volume":"9","author":"A Lenert","year":"2015","unstructured":"Lenert A, Lenert P (2015) Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF\/APRIL targeting agents. Drug Des Devel Ther 9:333\u2013347","journal-title":"Drug Des Devel Ther"},{"key":"4971_CR40","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/rheumatology\/kes123","volume":"51","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Odell E, Choong LM, Barone F, Fields P, Wilkins B, Tungekar FM, Patel P, Sanderson JD, Sangle S, D'Cruz D, Spencer J (2012) Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigen. Rheumatology (Oxford) 51:1580\u20131586","journal-title":"Rheumatology (Oxford)"},{"key":"4971_CR41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1212\/WNL.48.1.263","volume":"48","author":"M Spranger","year":"1997","unstructured":"Spranger M, Schwab S, Meinck HM, Tischendorf M, Sis J, Breitbart A, Andrassy K (1997) Meningeal involvement in Wegener\u2019s granulomatosis confirmed and monitored by positive circulating antineutrophil cytoplasm in cerebrospinal fluid. Neurology 48:263\u2013265","journal-title":"Neurology"},{"key":"4971_CR42","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/ndt\/15.6.893","volume":"15","author":"J Faust","year":"2000","unstructured":"Faust J, Visbeck A, Fitzek S, Fitzek C, Orth T, Wandel E, Mayet WJ (2000) Vasculitic wallenberg syndrome with detection of anti-proteinase 3 antibodies in the cerebrospinal fluid of a patient with severe Wegener\u2019s granulomatosis and only mild kidney involvement. Nephrol Dial Transplant 15:893\u2013896","journal-title":"Nephrol Dial Transplant"},{"key":"4971_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","volume":"24","author":"FB Vincent","year":"2013","unstructured":"Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F (2013) The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev 24:203\u2013215","journal-title":"Cytokine Growth Factor Rev"},{"key":"4971_CR44","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI0215034","volume":"109","author":"JV Stein","year":"2002","unstructured":"Stein JV, Lopez-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodriguez D, Gomez-Caro R, De Jong J, Martinez AC, Medema JP, Hahne M (2002) APRIL modulates B and T cell immunity. J Clin Invest 109:1587\u20131598","journal-title":"J Clin Invest"},{"key":"4971_CR45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"B Hellmich","year":"2007","unstructured":"Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66:605\u2013617","journal-title":"Ann Rheum Dis"},{"key":"4971_CR46","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalcindag N, Jayne DR, Mukhtyar C (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75:1583\u20131594","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04971-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-04971-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04971-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T02:59:08Z","timestamp":1612839548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-04971-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,8]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4971"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-04971-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,8]]},"assertion":[{"value":"22 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the Local Ethics Committee of Shinshu University. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}